Venus Remedies has unveiled a significant transformation of its consumer healthcare division, R3SET. This strategic pivot marks R3SET's foray into the wellness arena, coupled with the expansion of its pain management portfolio, showcasing the company's holistic approach to wellness solutions. According to recent data from Euromonitor, the Indian Consumer Healthcare market was valued at Rs 42,392 crore in 2023 and js projected to grow by a 4-5% CAGR till 2028.
The launch of R3SET Detox Candies, crafted with a blend of natural herbs such as Kalmegh, Punamava, Daru Haldi, Manjistha and Guduchi, positions the brand at the forefront of the wellness journey. These candies serve as effective liver detoxifiers and stress relievers, offering consumers a 'Dose of Good' with each bite. Available in two convenient packaging options - a 30- candy box and a 60-candy box-they cater to the growing demand for healthy products.
Simultaneously, R3SET is fortifying its pain-management portfolio with the introduction of the R3SET Ultra Potent Gel. This advanced gel, filled in a strikingly luxurious ceramic jar in loos packing with twice the effectiveness of its predecessor, reflects R3SET's commitment to delivering long-term healing solutions for body pain management.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |